Booster shots available at IH21 with moderate to severe immune compromise due to a medical condition.
Call to Register 1.800.451.6889, Option 1
CDC recommends that people who are moderately to severely immunocompromised receive an additional dose of an mRNA COVID-19 Vaccine (Pfizer-BioNTech or Moderna) at least 28 days after completion of the initial mRNA COVID-19 vaccine series. With emerging evidence showing some people who are
immunocompromised experienced a reduced immune response to the initial COVID-19 vaccine series, this update aims to prevent serious and possibly life-threatening COVID-19 within this population.
Q: Who is eligible to get the additional dose?
A: The additional vaccine should be considered for people with moderate to severe immune compromise due to a medical condition, or receipt of immunosuppressive medications or treatments. This includes people who have:
- Active treatment for solid tumor and hematologic malignancies
- Receipt of a solid-organ transplant and taking immunosuppressive therapy
- Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
- Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids (≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory
Please call to Register: 412-481-1644. Option 1
MORE COVID-19 SERVICES:
